| 764488 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
425 Pembrolizumab + vibostolimab in patients with adenocarcinoma metastatic castration-resistant prostate cancer (mCRPC) or treatment-emergent neuroendocrine mCRPC: phase 1b/2 KEYNOTE-365 cohorts G/H |
2021-11-01 |
10.1136/jitc-2021-sitc2021.425 |
Shore Neal, Bono Johann De, Kramer Gero, Joshua Anthony, Li Xin Tong, Poehlein Christian, Schloss Charles, Yu Evan |
| 764487 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
303 Non-functional T cell responses in non-small cell lung cancer are induced during tumor antigen-specific T cell priming in the mediastinal lymph node |
2021-11-01 |
10.1136/jitc-2021-sitc2021.303 |
Horton Brendan, Morgan Duncan, Torres-Mejia Elen, Zagorulya Maria, Bhandarkar Vidit, Momin Noor, Wittrup K, Love J, Spranger Stefani |
| 764486 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
302 Characterization of TIGIT and PVR expression in colorectal liver metastases |
2021-11-01 |
10.1136/jitc-2021-sitc2021.302 |
Bernard Antoine, Henault David, Pelletier Sandy, Thebault Pamela, Barrette Benoit, Turcotte Simon |
| 764485 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
2021-11-01 |
10.1136/jitc-2021-sitc2021.301 |
Hartl Christina, Michels Tillmann, Milde Ronny, Klein Vanessa, Beckhove Philipp, Loferer Hannes, Bissinger Stefan |
| 764484 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
294 Evaluation of radiographic response in the intact renal mass (intact-Rmass) to immune checkpoint inhibitor (ICI) combination regimens in patients with metastatic renal cell carcinoma (mRCC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.294 |
Emamekhoo Hamid, Hester Danubia, Abbasi Saqib, Eickhoff Jens, Bice Tristan, Archaya Luna, Jeager Ellen, Ornstein Moshe, Pirasteh Ali, Barata Pedro, Zakharia Yousef, Kilari Deepak, Wulff-Burchfield Elizabeth, Kyriakopoulos Christos |
| 764483 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
292 Ex vivo profiling of PD-1 blockade using an organotypic tissue slice model in solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.292 |
Ding Lina, Sullivan Kristin, Zhou Chensheng, Trillo-Tinoco Jimena, Lewin Anne, King Catherine, Nelson David, Chen Benjamin, Bowden Michaela |
| 764482 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
289 Cadonilimab, an anti-PD1/CTLA4 bi-specific antibody with Fc effector null backbone |
2021-11-01 |
10.1136/jitc-2021-sitc2021.289 |
Huang Zhaoliang, Pang Xinghua, Zhong Tingting, Chen Na, He Xinrong, Xia Dennis, Jin Xiaoping, Wang Zhongmin, Xia Xu, Li Baiyong |
| 764481 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
288 The COX-2 pathway as a mediator of resistance to anti-PD-1 therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.288 |
Chen Shuming, McMiller Tracee, Sankaran Preethi, Kampta Kyle, Topalian Suzanne |
| 764480 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
287 Combined COX-2 inhibition with fish oil and aspirin as adjuncts to anti-PD-1 immunotherapy in metastatic melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.287 |
Chacon Alexander, Melucci Alexa, Qin Shuyang, Burchard Paul, Jackson Katherine, Jewell Rachel, Prieto Peter |
| 764479 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
286 Sex differences in the transcriptional profiles of mucosal-associated invariant T cells in neoadjuvant anti-PD-1 treated non-small cell lung cancer (NSCLC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.286 |
Burman Poromendro, Zhang Boyang, Ji Zhicheng, Caushi Justina, Housseau Frank, Pardoll Andrew, Jiajia Zhang, Ji Hongkai, Smith Kellie |
